About MABLOC, LLC
Mabloc is a company leveraging AI to revolutionize antibody development, aiming to deliver life-saving therapies faster and at scale. Their BRAID™ platform accelerates the discovery and development of antibodies for a wide range of diseases.
AI-driven antibody discovery and developmentRapid identification of high-potential antibody candidatesStreamlining of drug development phases from discovery to clinical trialsAdaptable therapies for rapidly mutating pathogens
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MABLOC, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.